D. Zimbroff

发表

Efficacy and Safety of Oral Aripiprazole Compared with Haloperidol in Patients Transitioning from Acute Treatment with Intramuscular Formulations

G. Currier, D. Crandall, D. Daniel, 2007, Journal of psychiatric practice.

Best clinical practice with ziprasidone IM: update after 2 years of experience.

L. Citrome, D. Zimbroff, M. Allen, 2005, CNS spectrums.

Ziprasidone 80 mg/day and 160 mg/day in the Acute Exacerbation of Schizophrenia and Schizoaffective Disorder: A 6-Week Placebo-Controlled Trial

S. Potkin, D. Daniel, D. Zimbroff, 1999, Neuropsychopharmacology.

Intramuscular antipsychotics: clinical experience review.

G. Currier, A. Jagoda, D. Daniel, 2004, Journal of Emergency Medicine.

Switching patients from clozapine to risperidone therapy.

D. Zimbroff, 1995, The American journal of psychiatry.

Standard therapies for acute agitation.

G. Currier, A. Jagoda, D. Daniel, 2004, The Journal of emergency medicine.

Treatment of schizophrenia 1999

L. Siever, K. Davis, L. DeLisi, 1999 .

Selegiline transdermal system for the treatment of major depressive disorder: an 8-week, double-blind, placebo-controlled, flexible-dose titration trial.

K. Rickels, M. Rynn, D. Zimbroff, 2006, The Journal of clinical psychiatry.

Safety of medications used to treat acute agitation.

G. Currier, A. Jagoda, D. Daniel, 2004, The Journal of emergency medicine.

Intramuscular Aripiprazole in the Control of Agitation

G. Currier, D. Crandall, L. Citrome, 2007, Journal of psychiatric practice.

The tolerability of intramuscular ziprasidone and haloperidol treatment and the transition to oral therapy

D. Daniel, D. Zimbroff, E. Harrigan, 2004, International clinical psychopharmacology.

Pharmacological Control of Acute Agitation

D. Zimbroff, 2008 .

Pregabalin in generalized anxiety disorder: a placebo-controlled trial.

J. Davidson, C. Janney, D. Zimbroff, 2003, The American journal of psychiatry.

Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.

M. Pollack, R. Lydiard, K. Rickels, 2005, Archives of general psychiatry.

Best clinical practice with ziprasidone: update after one year of experience.

P. Weiden, R. Tandon, D. Zimbroff, 2002, Journal of psychiatric practice.

Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.

J. Kane, R. Mcquade, D. Zimbroff, 2002, The Journal of clinical psychiatry.

Novel therapies for treating acute agitation.

G. Currier, A. Jagoda, D. Daniel, 2004, Journal of Emergency Medicine.

Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.

D. Spyker, D. Zimbroff, M. Allen, 2011, The Journal of clinical psychiatry.

Management of Acute Agitation in Patients With Bipolar Disorder: Efficacy and Safety of Intramuscular Aripiprazole

R. Mcquade, D. Oren, D. Zimbroff, 2007, Journal of clinical psychopharmacology.

Management of Acute Psychosis: From Emergency to Stabilization

D. Zimbroff, 2003, CNS Spectrums.

Safety and tolerability of IM ziprasidone: Review of clinical trial data

D. Zimbroff, I. Benattia, S. Brook, 2002, European Neuropsychopharmacology.

Effects of PRX-00023, a Novel, Selective Serotonin 1A Receptor Agonist on Measures of Anxiety and Depression in Generalized Anxiety Disorder: Results of a Double-Blind, Placebo-Controlled Trial

E. Parsons, S. Mathew, K. Rickels, 2008, Journal of clinical psychopharmacology.

Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group.

C. Tamminga, J. Kane, D. Daniel, 1997, The American journal of psychiatry.

Patient and rater education of expectations in clinical trials (PREECT).

D. Zimbroff, 2001, Journal of clinical psychopharmacology.

Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder

T. Delmonte, A. Shekhar, D. Oren, 2010, Depression and anxiety.

Updated treatment algorithm.

G. Currier, A. Jagoda, D. Daniel, 2004, The Journal of emergency medicine.

Comparison of ziprasidone and aripiprazole in acutely ill patients with schizophrenia or schizoaffective disorder: a randomized, double-blind, 4-week study

D. Zimbroff, A. Loebel, C. Siu, 2007, International clinical psychopharmacology.

Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).

Alan I Green, Steven Potkin, Herbert Y Meltzer, 2003, Archives of general psychiatry.

Untitled Page

D. Zimbroff, H. Preval, Michael H. Allen, 2012 .

Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial

Chuanchieh Hsu, Steven G Potkin, Ravi Anand, 2003, Biological Psychiatry.

Multicenter, randomized, double‐blind, active comparator and placebo‐controlled trial of a corticotropin‐releasing factor receptor‐1 antagonist in generalized anxiety disorder

T. Delmonte, A. Shekhar, D. Oren, 2010, Depression and anxiety.